Literature DB >> 29415227

Successful use of secukinumab in a 4-year-old patient with deficiency of interleukin-36 antagonist.

Katharina Köstner1, Martina Prelog2, Giovanni Almanzar2, Heike Fesq3, Johannes-Peter Haas1, Boris Hügle1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29415227     DOI： 10.1093/rheumatology/kex510

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  4 in total

Review 1.  Biologic Treatment Options for Pediatric Psoriasis and Atopic Dermatitis-A Review.

Authors:  Abigail Cline; Andrew Berg; Gregory J Bartos; Lindsay C Strowd; Steven R Feldman
Journal:  J Clin Aesthet Dermatol       Date:  2020-06-01

2.  Efficacy and safety of secukinumab for the treatment of severe ABCA12 deficiency-related ichthyosis in a child.

Authors:  J Yogarajah; C Gouveia; J Iype; S Häfliger; A Schaller; J M Nuoffer; M Fux; M Gautschi
Journal:  Skin Health Dis       Date:  2021-05-03

Review 3.  The classification, genetic diagnosis and modelling of monogenic autoinflammatory disorders.

Authors:  Fiona Moghaddas; Seth L Masters
Journal:  Clin Sci (Lond)       Date:  2018-09-05       Impact factor: 6.124

Review 4.  Biologic Treatment Options for Pediatric Psoriasis and Atopic Dermatitis.

Authors:  Abigail Cline; Gregory J Bartos; Lindsay C Strowd; Steven R Feldman
Journal:  Children (Basel)       Date:  2019-09-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.